Overview

[18F]-AraG PET Imaging in LA HNSCC

Status:
NOT_YET_RECRUITING

Trial end date:
2027-10-01

Target enrollment:

Participant gender:

Summary

This study will use \[18F\]-AraG PET/CT scans to monitor patients who have been diagnosed with locally advanced Head and Neck Squamous Cell carcinoma (LA-HNSCC), and are planning to undergo standard of care chemoradiotherapy for treatment.

Phase:

EARLY_PHASE1

Details

Lead Sponsor:

Indiana University

Collaborator:

CellSight Technologies, Inc.

Treatments:

Drug Therapy
Radiotherapy